EyeGene Inc. announced a private placement to issue 5,551,444 shares at an issue price of KRW 2,702 for the gross proceeds of KRW 15,000,001,688 on December 13, 2023. The transaction will include participation from new investor BMI Korea Co., Ltd. for 5,551,444 shares. The transaction has been approved by the shareholders of the company and is expected to close on December 21, 2023.

The securities are restricted to a hold period of one year.